- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Bulletin 16/October/ 2021 - Video
Overview
Here are the top Health stories of the day
NMC directs major changes in Medical Education Curriculum, Textbooks to make them LGBTQIA friendly
Complying with the suggestions and views put forward by the Madras High Court on the 'queerphobia' in MBBS and PG medical courses, the National Medical Commission (NMC), while addressing the issue raised by the LGBTOIA+ Community, has directed necessary changes in competencies of CBME curriculum.
Issuing an advisory for all medical institutions across the country, the apex medical regulator has asked the concerned authorities as well as authors to amend the information in the textbooks and not recommend those textbooks and data with unscientific and discriminatory information about virginity, LGBTQIA+ Community, and homosexuals.
For more details, check out the full story on the link below:
MD - DNB equivalence to be medical teacher
With the release of its draft Teachers Eligibility Qualifications Regulations 2021 (TEQ), the National Medical Commission, has spelt out the basic requirements for medical teachers spelling out the entry points Medical Academia. Amoungst other rules, the guidelines also specify criteria for establishing MD-DNB equivalence for PG as well as super specialsations
Medical Dialogues had repeatedly written about the severe disadvantage that the DNB candidates were put to when the erstwhile MCI in 2017 had amended the regulations to call for a blanket additional 2-year SRship on all DNB passouts who were wanting to enter medical academia. Later, after much flack from the medical fraternity, in 2018, MCI partially took back the said guidelines, and presented new ones where equivalence was established for DNB degrees from Hospitals having more than 500 beds and where one of the three DNB supervisors classified to be eligible as as MCI faculty under the norms. At the same time those who had passed from less than institutions with 500 beds would have to do additional one year SRship.
For more details, check out the full story on the link below:
Days after enforcing the new Medical Termination of Pregnancy Act (MTP Act), the government has now notified new rules under which the upper limit for termination of a pregnancy has been increased from 20 to 24 weeks for certain categories of women.
According to the Medical Termination of Pregnancy (Amendment) Rules, 2021, these categories include survivors of sexual assault or rape or incest, minors and women whose marital status changes during an ongoing pregnancy (widowhood and divorce) and women with physical disabilities.
For more details, check out the full story on the link below:
U.S. Food and Drug Administration scientists said on Wednesday they did not receive enough data in time to do their own analysis of Johnson & Johnson's application for a booster dose of its COVID-19 vaccine, but the agency's review of company studies raised some red flags.
Advisers to the FDA will meet on Oct. 15 to assess the risks and benefits of a booster shot of J&J's vaccine, which is currently given as a single dose.
For more details, check out the full story on the link below: